The Many Ways to Deal with STING

The stimulator of interferon genes (STING) is an adaptor protein involved in the activation of IFN-β and many other genes associated with the immune response activation in vertebrates. STING induction has gained attention from different angles such as the potential to trigger an early immune respons...

Full description

Bibliographic Details
Main Authors: Claire Coderch, Javier Arranz-Herrero, Estanislao Nistal-Villan, Beatriz de Pascual-Teresa, Sergio Rius-Rocabert
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/10/9032
_version_ 1797599762882494464
author Claire Coderch
Javier Arranz-Herrero
Estanislao Nistal-Villan
Beatriz de Pascual-Teresa
Sergio Rius-Rocabert
author_facet Claire Coderch
Javier Arranz-Herrero
Estanislao Nistal-Villan
Beatriz de Pascual-Teresa
Sergio Rius-Rocabert
author_sort Claire Coderch
collection DOAJ
description The stimulator of interferon genes (STING) is an adaptor protein involved in the activation of IFN-β and many other genes associated with the immune response activation in vertebrates. STING induction has gained attention from different angles such as the potential to trigger an early immune response against different signs of infection and cell damage, or to be used as an adjuvant in cancer immune treatments. Pharmacological control of aberrant STING activation can be used to mitigate the pathology of some autoimmune diseases. The STING structure has a well-defined ligand binding site that can harbor natural ligands such as specific purine cyclic di-nucleotides (CDN). In addition to a canonical stimulation by CDNs, other non-canonical stimuli have also been described, whose exact mechanism has not been well defined. Understanding the molecular insights underlying the activation of STING is important to realize the different angles that need to be considered when designing new STING-binding molecules as therapeutic drugs since STING acts as a versatile platform for immune modulators. This review analyzes the different determinants of STING regulation from the structural, molecular, and cell biology points of view.
first_indexed 2024-03-11T03:38:54Z
format Article
id doaj.art-bf27122d3e5547e7b47c79a92bee594a
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:38:54Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-bf27122d3e5547e7b47c79a92bee594a2023-11-18T01:46:13ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-012410903210.3390/ijms24109032The Many Ways to Deal with STINGClaire Coderch0Javier Arranz-Herrero1Estanislao Nistal-Villan2Beatriz de Pascual-Teresa3Sergio Rius-Rocabert4Departamento de Química y Bioquímica, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28668 Boadilla del Monte, SpainTransplant Immunology Unit, National Center of Microbiology, Instituto de Salud Carlos III, 28220 Majadahonda, SpainDepartamento CC, Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28668 Boadilla del Monte, SpainDepartamento de Química y Bioquímica, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28668 Boadilla del Monte, SpainDepartamento CC, Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28668 Boadilla del Monte, SpainThe stimulator of interferon genes (STING) is an adaptor protein involved in the activation of IFN-β and many other genes associated with the immune response activation in vertebrates. STING induction has gained attention from different angles such as the potential to trigger an early immune response against different signs of infection and cell damage, or to be used as an adjuvant in cancer immune treatments. Pharmacological control of aberrant STING activation can be used to mitigate the pathology of some autoimmune diseases. The STING structure has a well-defined ligand binding site that can harbor natural ligands such as specific purine cyclic di-nucleotides (CDN). In addition to a canonical stimulation by CDNs, other non-canonical stimuli have also been described, whose exact mechanism has not been well defined. Understanding the molecular insights underlying the activation of STING is important to realize the different angles that need to be considered when designing new STING-binding molecules as therapeutic drugs since STING acts as a versatile platform for immune modulators. This review analyzes the different determinants of STING regulation from the structural, molecular, and cell biology points of view.https://www.mdpi.com/1422-0067/24/10/9032STINGIFNantiviral response
spellingShingle Claire Coderch
Javier Arranz-Herrero
Estanislao Nistal-Villan
Beatriz de Pascual-Teresa
Sergio Rius-Rocabert
The Many Ways to Deal with STING
International Journal of Molecular Sciences
STING
IFN
antiviral response
title The Many Ways to Deal with STING
title_full The Many Ways to Deal with STING
title_fullStr The Many Ways to Deal with STING
title_full_unstemmed The Many Ways to Deal with STING
title_short The Many Ways to Deal with STING
title_sort many ways to deal with sting
topic STING
IFN
antiviral response
url https://www.mdpi.com/1422-0067/24/10/9032
work_keys_str_mv AT clairecoderch themanywaystodealwithsting
AT javierarranzherrero themanywaystodealwithsting
AT estanislaonistalvillan themanywaystodealwithsting
AT beatrizdepascualteresa themanywaystodealwithsting
AT sergioriusrocabert themanywaystodealwithsting
AT clairecoderch manywaystodealwithsting
AT javierarranzherrero manywaystodealwithsting
AT estanislaonistalvillan manywaystodealwithsting
AT beatrizdepascualteresa manywaystodealwithsting
AT sergioriusrocabert manywaystodealwithsting